Marks latest milestone in company’s previously announced $23 billion investment in US infrastructure ...
Phase III trial for KLU156 (ganaplacide/lumefantrine, or GanLum), meets primary endpoint of non-inferiority to standard of care Coartem® (artemether-lumefantrine) Demonstrates PCR-corrected cure rate ...
Explore opportunities with Novartis and Sandoz below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search.
Zistite viac o príležitostiach v spoločnosti Novartis. Pre ďalšie pracovné ponuky v Novartis Gene Therapies (predtým AveXis) navštívte GTx Career Search . Oznámenie pre uchádzačov o voľné pracovné ...
Assoc. Dir. DDIT DEV Data Analytics DS&AI Regular, Full time Information Technology India Hyderabad Office nov 13, 2025 Data Anonymization Analyst Regular, Full time Research India Hyderabad Office ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback